Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|December 28, 2016
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics ConsortiumC H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell CarcinomaXiaoyan Liu, Jesse J Swen, Meta H M Diekstra, et al.
International Journal of Antimicrobial Agents|January 15, 2023
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trialAnette Veringa, Roger J Brüggemann, Lambert F R Span, et al.
Pharmacogenetics and Genomics|April 23, 2020
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE studyCathelijne H van der Wouden, Stefan Böhringer, Erika Cecchin, et al.
Current Drug Metabolism|February 1, 2014
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development processKelly E Caudle, Teri E Klein, James M Hoffman, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2022
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patientsEmma C Hulshof, Mirjam de With, Femke M de Man, et al.
Clinical Pharmacology and Therapeutics|April 9, 2022
Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical StudyMirjam de With, Jonathan Knikman, Femke M de Man, et al.
Cancers|June 24, 2022
Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with SunitinibMeta H M Diekstra, Jesse J Swen, Loes F M van der Zanden, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014
Evidence synthesis and guideline development in genomic medicine: current status and future prospectsSheri D Schully, Tram Kim Lam, W David Dotson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair AnalysisJonathan E Knikman, Tycho A Wilting, Marta Lopez-Yurda, et al.
Pageof 19